PharmaChemical Ireland welcomes Amgen purchase of Pfizer’s Dublin facility

PharmaChemical Ireland, the IBEC group that represents the pharmaceutical and chemical industry, today welcomed the news that Amgen has agreed to purchase Pfizer’s manufacturing facility in Dun Laoghaire, Co Dublin. The majority of the employees (approximately 240) are expected transfer across, while a smaller number (40) will continue to work for Pfizer.

PharmaChemical Ireland Director Matt Moran said: “The move will secure jobs and is further proof of Ireland’s attractiveness as a place to invest and do business. Despite a difficult economic environment, the pharmaceuticals industry has a fantastic track record in this country. We have the people, the capability and the drive to meet the challenges ahead.

“Amgen is one of the leading global pharmaceutical players and their presence here further enhances Ireland’s reputation as a global hub for the industry. IDA Ireland is to be congratulated for landing this important investment.”

Eight of the top 10 pharmaceuticals companies in the world have major operations in Ireland, benefiting from a favourable tax regime, a highly-skilled workforce, strong compliance record and easy access to European markets. The industry accounts for over half the national exports in value terms – some €50 billion in 2010, employs over 24,500 people and contributes €1 billion in corporation tax annually.